179 related articles for article (PubMed ID: 11269735)
21. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of TJ-8117 (Onpi-to), a drug for renal failure (I): Plasma concentration, distribution and excretion of [3H]-(-)epicatechin 3-O-gallate in rats and dogs.
Takizawa Y; Nishimura H; Morota T; Tomisawa H; Takeda S; Aburada M
Eur J Drug Metab Pharmacokinet; 2004; 29(2):91-101. PubMed ID: 15230336
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure.
Zamek-Gliszczynski MJ; Abraham TL; Alberts JJ; Kulanthaivel P; Jackson KA; Chow KH; McCann DJ; Hu H; Anderson S; Furr NA; Barbuch RJ; Cassidy KC
Drug Metab Dispos; 2013 Apr; 41(4):714-26. PubMed ID: 23305709
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
25. The effect of different dosing schedules of UCN-01 on its pharmacokinetics and cardiohaemodynamics in dogs.
Kurata N; Imabeppu S; Nitoh M; Kobayashi H; Kuwabara T; Kobayashi S
J Pharm Pharmacol; 2000 Nov; 52(11):1327-35. PubMed ID: 11186240
[TBL] [Abstract][Full Text] [Related]
26. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
Tokuma Y; Fujiwara T; Noguchi H
Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
[TBL] [Abstract][Full Text] [Related]
27. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.
Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T
Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021
[TBL] [Abstract][Full Text] [Related]
28. Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog.
Uchida T; Nakamura E; Usui T; Imasaki H; Kawakami R; Watanabe T; Higuchi S
Xenobiotica; 1994 Dec; 24(12):1223-36. PubMed ID: 7771109
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of metabolism and disposition of GDC-0152 in rats using 14C labeling strategy at two different positions: a novel formation of hippuric acid from 4-phenyl-5-amino-1,2,3-thiadiazole.
Yue Q; Mulder T; Rudewicz PJ; Solon E; Budha N; Ware JA; Lyssikatos J; Hop CE; Wong H; Khojasteh SC
Drug Metab Dispos; 2013 Feb; 41(2):508-17. PubMed ID: 23223496
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of homoharringtonine in dogs.
Lu K; Savaraj N; Feun LG; Guo ZG; Umsawasdi T; Loo TL
Cancer Chemother Pharmacol; 1988; 21(2):139-42. PubMed ID: 3349562
[TBL] [Abstract][Full Text] [Related]
31. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of TAK-475, a Squalene Synthase Inhibitor, in Rats and Dogs.
Ebihara T; Teshima K; Kondo T; Tagawa Y; Moriwaki T; Asahi S
Drug Res (Stuttg); 2016 Jun; 66(6):287-92. PubMed ID: 26839207
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
[TBL] [Abstract][Full Text] [Related]
34. Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog.
Naitoh T; Mishima M; Kawaguchi S; Matsui K; Andoh T; Kagei K; Kakiki M; Yuzuriha T; Horie T
Xenobiotica; 1997 Oct; 27(10):1053-70. PubMed ID: 9364742
[TBL] [Abstract][Full Text] [Related]
35. Biliary excretion of colchicine.
Hunter AL; Klaassen CD
J Pharmacol Exp Ther; 1975 Mar; 192(3):605-17. PubMed ID: 1120958
[TBL] [Abstract][Full Text] [Related]
36. Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans.
Kumar GN; Jayanti VK; Johnson MK; Uchic J; Thomas S; Lee RD; Grabowski BA; Sham HL; Kempf DJ; Denissen JF; Marsh KC; Sun E; Roberts SA
Pharm Res; 2004 Sep; 21(9):1622-30. PubMed ID: 15497688
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
38. Absorption, distribution and excretion of the anti-tuberculosis drug delamanid in rats: Extensive tissue distribution suggests potential therapeutic value for extrapulmonary tuberculosis.
Shibata M; Shimokawa Y; Sasahara K; Yoda N; Sasabe H; Suzuki M; Umehara K
Biopharm Drug Dispos; 2017 May; 38(4):301-312. PubMed ID: 28092695
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
[TBL] [Abstract][Full Text] [Related]
40. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ
Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
